Jie Mao

7PUBLICATIONS
24CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devicesPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 05, 2026
Targeting SLC38A5 Overcomes αPD-1 Immunotherapy Resistance by Alleviating Glutamine Competition Between Glioblastoma Cells and T Cells.

|Mar 03, 2026
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.

Jiayi Zhou, Yinggui Yang, Ran Ye

|Aug 14, 2024
ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia/macrophages.

Tao Chen, Jiangang Liu, Chenci Wang

|Feb 13, 2021
miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities.

Xinzhi Yang, Jiangang Liu, Chenci Wang

|Apr 23, 2020
LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.

Hongchao Xu, Beilin Zhang, Yinggui Yang

|Apr 16, 2020
Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin.

Zhuohao Liu, Ruixiang Ge, Jiayi Zhou

Pageof 2

Frequent Collaborators

4 joint publications

Zhuohao Liu

2 joint publications

Dinglan Wu

1 joint publications

Delong Zhang

1 joint publications

Huanggui Zhou